علاج فرط بوتاسيوم الدم الشديد في مرضى غسيل الكلى الصيانة

References

• We recommend that haemodialysis patients with severe hyperkalaemia (serum K+ ≥ 6.5 mmol/L) receive dialysis treatment urgently.
• We recommend that haemodialysis patients with severe hyperkalaemia (serum K+ ≥ 6.5 mmol/L) and toxic ECG changes be treated with intravenous calcium salt to reduce risk of arrhythmias even when dialysis is immediately available.
• We recommend that haemodialysis patients with severe hyperkalaemia (serum K+ ≥ 6.5 mmol/L) be treated with standard medical therapies to lower serum potassium if dialysis is not immediately available.
• We suggest that potassium binders may be considered to reduce the risk of hyperkalaemia during the inter-dialytic period.